SAN FRANCISCO, Jan. 8, 2018 /PRNewswire/ -- ExL Events is hosting the inaugural Cannabis Partnerships Congress taking place March 12-13, 2018 at the Hilton San Francisco Airport Bayfront in San Francisco, CA.
This congress will offer key insights from all stakeholders that are involved in the cannabis industry, covering a variety of topics between scientific, medicinal, governmental and research development. There will be discussions about legislative hurdles, current and planned cannabinoid developments, and discovering how to improve the quality and efficiency of data integrity in clinical trials.
There has been continued enforcement of restrictive policies and regulations on research into the health benefits; therefore this is a great opportunity for those involved to understand the obstacles in order to enhance product development. To view the full agenda, click here.
Featured Speakers:
To register, please visit https://goo.gl/sXhGgY and use Priority Code C1033PRnews.
For more information, contact: ExL EventsPhone: 866-207-6528Email: registration @exlevents.com
Advertisement
This congress will offer key insights from all stakeholders that are involved in the cannabis industry, covering a variety of topics between scientific, medicinal, governmental and research development. There will be discussions about legislative hurdles, current and planned cannabinoid developments, and discovering how to improve the quality and efficiency of data integrity in clinical trials.
Advertisement
There has been continued enforcement of restrictive policies and regulations on research into the health benefits; therefore this is a great opportunity for those involved to understand the obstacles in order to enhance product development. To view the full agenda, click here.
Featured Speakers:
- Bruce Bloom, CEO, CURES WITHIN REACH
- Dean Petkanas, Chief Medical Officer, KANNALIFE SCIENCES
- Veronica Arroyave, Sr. Director, Global Health Programs, PARTNERSHIP FOR QUALITY MEDICAL DONATIONS
- Bruno Battistini, President, CEO and Scientific Director, NEW BRUNSWICK HEALTH RESEARCH FOUNDATION
- Doug Brennaman, Scientific Advisory Board, KANNALIFE SCIENCES
- Jerry Bryant, Managing Member, VYRIPHARM BIOPHARMACEUTICAL
- Guy Chamberland, M.Sc., Master Herbalist, Chief Scientific Officer and Regulatory Affairs, TETRA BIO-PHARMA
- Jeffrey Chen, Director, UCLA CANNABIS RESEARCH INITIATIVE
- Lezli Engelking, President and Founder, FOCUS
- Elias Jackson, Ph.D., President of Research and Development, VYRIPHARM BIOPHARMACEUTICAL
- Thoma Kikis, Chief Marketing Officer, KANNALIFE SCIENCES
- Darshan Kulkarni, FDA Regulatory and Compliance Attorney, KULKARNI LAW FIRM
- Kimberly Lincoln, Manufacturing Scientist, ROCHE
- Barbara Read, Vice President of Sales and Marketing, LIFESCRIPT
- Mark Reichman, EVP, Client Services Director, Cannabis Patient Advocate, GUIDEMARK HEALTH
- Jeremy Unruh, General Counsel and Chief Compliance Officer, PHARMACANN LLC
To register, please visit https://goo.gl/sXhGgY and use Priority Code C1033PRnews.
For more information, contact: ExL EventsPhone: 866-207-6528Email: registration @exlevents.com
View original content:http://www.prnewswire.com/news-releases/advancing-cannabinoid-science-by-driving-effective-cannabinoid-research-overcoming-the-hurdles-of-therapeutics-production-regulatory-and-medicinal-approvals-300578302.html
SOURCE ExL Events
